The BIO-Europe 2025 conference, taking place November 3–5, 2025, in Vienna, is recognized as Europe’s leading life science partnering event. Each year, it brings together around 5,700 participants from over 60 countries, including biotechnology and pharmaceutical companies, investors, and service providers. For more than three decades, it has served as a central meeting place for establishing strategic relationships and advancing innovation across the industry.

As one of the most efficient forums worldwide for exploring licensing and collaboration opportunities, BIO-Europe features thousands of meetings arranged through its partneringONE® platform, along with company presentations, panel discussions, and an active exhibition.

EffRx proactively seeks commercialization partners for its lead product Binosto® in South East Asian and LATAM territories and in-licensing opportunities in Europe in niche therapeutic areas, with a particular focus on rare diseases, endocrinology, and musculoskeletal disorders, and will meet with prospective partners to discuss potential collaborations.